Earlier this morning, Bill Ackman sent a love letter to the Allergan board of directors to which Allergan, Inc. (NYSE:AGN) has responded, as exclusively reported in ValueWalk. “We have read your recent SEC filings and published reports which state that you are negotiating a potential merger transaction with a third party, widely reported to be Actavis plc (NYSE:ACT),” the letter starts, as Ackman immediately addresses the elephant in the room: the other lover. Yesterday in Chicago Ackman seemed perturbed at the object of his desire, saying he wanted the CEO of Allergan to be fired. Today, the tone is more…
Ackman Love Letter To Allergan This Morning Shows Desire
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.
Comments are closed.